- Home
- QH vs ALBT Comparison
QH vs ALBT Comparison
Compare QH & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QH | ALBT |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 5.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | QH | ALBT |
|---|---|---|
| Price | $1.15 | $1.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 828.8K | 179.8K |
| Earning Date | 09-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $357,118,848.00 | $1,611,940.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.37 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.74 | $0.88 |
| 52 Week High | $169.07 | $11.66 |
Technical Indicators
Market Signals| Indicator | QH | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 41.98 |
| Support Level | $1.23 | $0.88 |
| Resistance Level | $2.20 | $1.77 |
| Average True Range (ATR) | 0.25 | 0.19 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 11.24 | 36.64 |
Price Performance
Historical ComparisonAbout QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.